SK Biopharmaceuticals in South Korea and Japanese firm Ono Pharmaceutical announced that they have entered into an exclu...
Japan-based Astellas Pharma Inc. and Seagen Inc. in the US have announced positive topline results from the second cohor...
Japanese firm Takeda Pharmaceutical has entered into a five-year strategic agreement with Accenture and Amazon Web Servi...
Olympus Corporation has announced the launch of ENDO-AID, a cutting-edge platform powered by artificial intelligence (AI...
The University of Tokyo and Eisai Co., Ltd. have announced a collaboration aiming for the development and drug discovery...
The present pandemic scenarios are continuing to place immense pressure on healthcare systems across Asia Pacific (APAC)...
Japan-based Takeda Pharmaceutical Company Limited (Takeda) and Arrowhead Pharmaceuticals Inc. in the US have announced a...
Japanese firm Santen Pharmaceutical and Orbis International in the US have announced a long-term, ten-year partnership t...
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, a leader...
The Nagase R&D Center, the research and development arm of NAGASE & CO., LTD. based in Tokyo, has been deve...
Japan's Eisai has entered into a joint research agreement with four research organizations (KAN Research Institute, Nati...
Researchers from Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and Tokai University i...
Shionogi & Co. and HanaVax Inc., both based in Japan, have announced they have entered into a license agreement for ...
Shionogi & Co. Ltd., a global, research-driven pharmaceutical company headquartered in Osaka, Japan (Shionogi) has r...
Japanese firm OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gen...
Japan's Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development a...
Japanese researchers have launched the Joint Research Coronavirus Task Force to gather genetic information for predictin...
The Global Health Innovative Technology (GHIT) Fund in Japan has announced a total of 1.37 billion yen to invest in...
